External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
暂无分享，去创建一个
C. Stief | M. Hohenfellner | J. Ellinger | C. Bolenz | S. Müller | L. Trojan | P. Bastian | P. Nuhn | A. Buchner | F. May | D. Tilki | J. Roigas | H. Fritsche | A. Haferkamp | C. Wülfing | E. Herrmann | M. Zacharias | S. Brookman-May | C. Gilfrich | M. May | W. Wieland | R. Moritz | M. Burger | S. Melchior | T. Höfner | Christian Gilfrich | Markus Hohenfellner | Matthias May | S. Brookman-May | Christian Bolenz | Jörg Ellinger | D. Tilki | A. Haferkamp | Patrick J Bastian | A. Buchner | Edwin Herrmann | Christian Wülfing | Florian May